AU2002366709A1 - Nucleotide polymorphisms associated with osteoporosis - Google Patents

Nucleotide polymorphisms associated with osteoporosis

Info

Publication number: AU2002366709A1
Authority: AU; Australia
Prior art keywords: osteoporosis; nucleotide polymorphisms; polymorphisms associated; nucleotide; polymorphisms
Prior art date: 2001-12-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002366709A

Other versions

AU2002366709A8 (en

Inventor

Simon Bennett

Nicolas Galwey

Karen Anne Jones

Jonathan Mangion

Ian Mckay

Alan Schafer

David J. Townley

Ana Valdes

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Incyte Corp

Original Assignee

Incyte Genomics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-20

Filing date

2002-12-19

Publication date

2003-07-09

2002-12-19 Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc

2003-07-09 Publication of AU2002366709A1 publication Critical patent/AU2002366709A1/en

2003-07-09 Publication of AU2002366709A8 publication Critical patent/AU2002366709A8/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Analytical Chemistry (AREA)
Wood Science & Technology (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Pathology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2002366709A 2001-12-20 2002-12-19 Nucleotide polymorphisms associated with osteoporosis Abandoned AU2002366709A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US34271101P	2001-12-20	2001-12-20
US60/342,711		2001-12-20
US42355902P	2002-11-04	2002-11-04
US60/423,559		2002-11-04
PCT/US2002/040948 WO2003054218A2 (en)	2001-12-20	2002-12-19	Nucleotide polymorphisms associated with osteoporosis

Publications (2)

Publication Number	Publication Date
AU2002366709A1 true AU2002366709A1 (en)	2003-07-09
AU2002366709A8 AU2002366709A8 (en)	2003-07-09

Family

ID=26993153

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002366709A Abandoned AU2002366709A1 (en)	2001-12-20	2002-12-19	Nucleotide polymorphisms associated with osteoporosis

Country Status (4)

Country	Link
EP (1)	EP1466012A2 (en)
AU (1)	AU2002366709A1 (en)
CA (1)	CA2471376A1 (en)
WO (1)	WO2003054218A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0301715D0 (en) *	2003-01-24	2003-02-26	King S College London	Detection of predisposition to osteoporosis
DK1644406T3 (en)	2003-07-11	2012-11-19	Develogen Ag	Use of DG153 secreted protein products to prevent and treat pancreatic and / or obesity and / or metabolic syndrome
CA3116028A1 (en) *	2018-10-09	2020-04-16	Genecentric Therapeutics, Inc.	Detecting tumor mutation burden with rna substrate

2002
- 2002-12-19 WO PCT/US2002/040948 patent/WO2003054218A2/en not_active Ceased
- 2002-12-19 EP EP02805650A patent/EP1466012A2/en not_active Withdrawn
- 2002-12-19 AU AU2002366709A patent/AU2002366709A1/en not_active Abandoned
- 2002-12-19 CA CA002471376A patent/CA2471376A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2003054218A3 (en)	2004-02-19
CA2471376A1 (en)	2003-07-03
EP1466012A2 (en)	2004-10-13
AU2002366709A8 (en)	2003-07-09
WO2003054218A2 (en)	2003-07-03

Similar Documents

Publication	Publication Date	Title
AU2002351077A1 (en)	2003-05-19	Oligonucleotides modified with novel alpha-l-rna analogues
AU2001272482A1 (en)	2002-01-02	Osteolevin gene polymorphisms
AU2001259561A1 (en)	2001-11-12	Tgfbeta-rii promoter polymorphisms
AU2002366713A1 (en)	2003-07-09	Nucleotide polymorphisms associated with osteoarthritis
AU2001245489A1 (en)	2001-09-17	Human single nucleotide polymorphisms
AU2002319233A1 (en)	2002-12-03	Interferon alpha-14 polymorphism
WO2003014319A9 (en)	2010-02-04	Polymorphisms associated with multiple sclerosis
AU2002366709A1 (en)	2003-07-09	Nucleotide polymorphisms associated with osteoporosis
AU2002307963A1 (en)	2002-11-25	Genetic typing
AU2002360349A1 (en)	2003-05-26	Single nucleotide polymorphisms in gh-1
AU2002324711A1 (en)	2003-03-18	Single nucleotide polymorphisms diagnostic for schizophrenia
AU2002334632A1 (en)	2003-04-01	Lipid-associated molecules
AU2002324955A1 (en)	2003-04-01	Regulatory single nucleotide polymorphisms and methods therefor
GB0229139D0 (en)	2003-01-15	Gene polymorphisms
AU2002309917A1 (en)	2002-12-03	Lipid-associated molecules
AU2002364894A1 (en)	2003-06-30	Single nucleotide polymorphisms and mutations on alpha-2-macroglobulin
AU2002214446A1 (en)	2002-05-15	Single nucleotide polymorphisms
AUPR918701A0 (en)	2001-12-20	Tile
AUPR282501A0 (en)	2001-02-22	Expression facilitating nucleotides
AU2002336406A1 (en)	2003-03-18	Allele specific pcr for genotyping
AU2001253091A1 (en)	2001-10-15	Haplotypes of the gp1ba gene
AU2002346278A1 (en)	2003-02-17	Tile
AU2001251524A1 (en)	2001-10-23	Haplotypes of the hsd3b2 gene
AU2002328863A1 (en)	2003-01-29	Oncosuppressive gene
AU2002249793A1 (en)	2002-08-12	Human single nucleotide polymorphisms

Legal Events

Date	Code	Title	Description
2004-09-16	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase